glp 1 sales GLP-1 Receptor Agonist Market Growth Analysis Pharma Giants Bet on Next-Generation

As more research emerges, we continue to refine our approaches to managing side effects and improving patient outcomes

A study of liraglutide identified 0.188 cases per 100 person-years (PY) versus 0.154 in patients taking MET (an SU) or pioglitazone (a TZD)

The good news is that these are very effective, and we keep getting better and better medications, Drucker said

Ultimately, the decision to start a GLP-1 should be made with a trusted healthcare professional who understands both the science and the unique challenges of menopause

Intramuscular injection typically causes more pain and tenderness at the site compared to a subcutaneous injection

A 2025 Kinsey Institute survey revealed that more than half of GLP-1 users said the drugs had changed their sex and dating livessometimes for the worse